True about low molecular weight heparin except:
Predictable bioavailability
Inhibit factor Ela and Xa
Favorable pharmacokinetics
PT, apt monitoring not required.
Ans. B. Inhibit factor IIa and XaLow molecular weight is sensitive to factor Xa. It has better bioavailability. Its response is predictable therefore monitoring of PT is not required. Example are- dalteparin, enoxaparin.
Hematology